<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nur Sofiatul Aini</style></author><author><style face="normal" font="default" size="100%">Arif Nur Muhammad Ansori</style></author><author><style face="normal" font="default" size="100%">Viol Dhea Kharisma</style></author><author><style face="normal" font="default" size="100%">Muhammad Farraz Syadzha</style></author><author><style face="normal" font="default" size="100%">Muhammad Hermawan Widyananda</style></author><author><style face="normal" font="default" size="100%">Ahmad Affan Ali Murtadlo</style></author><author><style face="normal" font="default" size="100%">Rasyadan Taufiq Probojati</style></author><author><style face="normal" font="default" size="100%">Md. Emdad Ullah</style></author><author><style face="normal" font="default" size="100%">Sin War Naw</style></author><author><style face="normal" font="default" size="100%">Vikash Jakhmola</style></author><author><style face="normal" font="default" size="100%">Rahadian Zainul</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Potential Roles of Purslane (Portulaca oleracea L.) as Antimetabolic Syndrome: A Review</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Body weight</style></keyword><keyword><style  face="normal" font="default" size="100%">Insulin resistance</style></keyword><keyword><style  face="normal" font="default" size="100%">Metabolic syndrome</style></keyword><keyword><style  face="normal" font="default" size="100%">Obesity.</style></keyword><keyword><style  face="normal" font="default" size="100%">Portulaca oleracea</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">710-714</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;The number of cases of obesity and type 2 diabetes mellitus (T2DM) is part of the metabolic syndrome case. Purslane (&lt;em&gt;Portulaca oleracea&lt;/em&gt; L.) is a plant that has been clinically tested and has the potential to prevent and treat metabolic syndrome as well as pathogenic and pathophysiological activities that cause disease. The aim of this study is to discuss and conclude information regarding the activity and use of purslane (&lt;em&gt;P. oleracea&lt;/em&gt;) as an antimetabolic. This review article is based on scientific publications found on Google Scholar and PubMed databases using the keywords of “Portulaca obesity”, “&lt;em&gt;Portulaca &lt;/em&gt;overweight”, “Portulaca dyslipidemia”, and “&lt;em&gt;Portulaca&lt;/em&gt; metabolic syndrome”. This plant acts on numerous pathways in the metabolic syndrome such as reduction of lipids, blood sugar, body weight and total cholesterol. Purslane (&lt;em&gt;P. oleracea&lt;/em&gt;) can be used as a candidate for a new herbal plant as an anti-metabolic syndrome.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><accession-num><style face="normal" font="default" size="100%">30</style></accession-num><section><style face="normal" font="default" size="100%">710</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Nur Sofiatul Aini&lt;sup&gt;1&lt;/sup&gt;, Arif Nur Muhammad Ansori&lt;sup&gt;2&lt;/sup&gt;, Viol Dhea Kharisma&lt;sup&gt;3,4&lt;/sup&gt;, Muhammad Farraz Syadzha&lt;sup&gt;4&lt;/sup&gt;, Muhammad Hermawan Widyananda&lt;sup&gt;3,4&lt;/sup&gt;, Ahmad Affan Ali Murtadlo&lt;sup&gt;4&lt;/sup&gt;, Rasyadan Taufiq Probojati&lt;sup&gt;4&lt;/sup&gt;, Md. Emdad Ullah&lt;sup&gt;5&lt;/sup&gt;, Sin War Naw&lt;sup&gt;6&lt;/sup&gt;, Vikash Jakhmola&lt;sup&gt;7&lt;/sup&gt;, Rahadian Zainul&lt;sup&gt;8,9,*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Mathematics and Natural Sciences, State University of Surabaya, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Professor Nidom Foundation, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Faculty of Mathematics and Natural Sciences, Brawijaya University, Malang, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Division of Molecular Biology and Genetics, Generasi Biologi Indonesia Foundation, Gresik, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Department of Chemistry, Mississippi State University, Mississippi State, UNITED STATES.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Department of Chemistry, Myitkyina University, Myitkyina, MYANMAR.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;7&lt;/sup&gt;Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;8&lt;/sup&gt;Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Negeri Padang, Padang, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;9&lt;/sup&gt;Center for Advanced Material Processing, Artificial Intelligence, and Biophysic Informatics (CAMPBIOTICS), Universitas Negeri Padang, Padang, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Guenzet Akila,</style></author><author><style face="normal" font="default" size="100%">Krouf Djamil,</style></author><author><style face="normal" font="default" size="100%">Berzou Saadia</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Portulaca oleracea extract increases lecithin:cholesterol acyltransferase and paraoxonase 1 activities and enhances reverse cholesterol transport in streptozotocin-induced diabetic rat</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">apo A-I</style></keyword><keyword><style  face="normal" font="default" size="100%">Cholesterol</style></keyword><keyword><style  face="normal" font="default" size="100%">LCAT</style></keyword><keyword><style  face="normal" font="default" size="100%">lipoprotein peroxidation</style></keyword><keyword><style  face="normal" font="default" size="100%">PON1</style></keyword><keyword><style  face="normal" font="default" size="100%">Portulaca oleracea</style></keyword><keyword><style  face="normal" font="default" size="100%">Rats</style></keyword><keyword><style  face="normal" font="default" size="100%">Streptozotocin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">8th April 2014</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">6</style></volume><pages><style face="normal" font="default" size="100%">1-9</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Plant extracts are generally assumed to be more acceptable and less hazardous than synthetic compounds and could be alternative antidiabetic treatments. &lt;em&gt;Portula caoleracea&lt;/em&gt; has been used as one of the traditional edible and medicinal plant in Algeria to treat diabetes. The aim of the present study was to determine the effects of lyophilized aqueous extract of &lt;em&gt;Portulaca oleracea&lt;/em&gt; on high-density lipoproteins composition, paraoxonase (PON1) and lecithin:cholesterol acyltransferase (LCAT) activities in streptozotocin-induced diabetic rat. &lt;strong&gt;Methods:&lt;/strong&gt; Diabetes was induced intraperitonially by a single injection of streptozotocin (STZ) (60mg/kg bw). Twelve diabetic rats, weighing 263&amp;plusmn;5g, were divided into two groups fed a casein diet supplemented or not with&lt;em&gt; Portulaca oleracea&lt;/em&gt; extract (1g/kg bw), for 4 weeks.&lt;strong&gt; Results:&lt;/strong&gt; At d28, in&lt;em&gt; Portulaca oleracea&lt;/em&gt; treated vs untreated diabetic group, glycemia, serum total cholesterol (TC), triacylglycerols (TG) and phospholipids (PL) concentrations were decreased significantly (&lt;em&gt;p&lt;/em&gt;&amp;lt;0.05). The hypolipidemic effect induced by &lt;em&gt;Portulaca oleracea&lt;/em&gt; extract was due to the reduction of total cholesterol (TC) in LDL-HDL&lt;sub&gt;1&lt;/sub&gt; (-51%) and C-HDL&lt;sub&gt;3&lt;/sub&gt; (-21%).&lt;em&gt; Portulaca oleracea&lt;/em&gt; treatment improved PON1 and LCAT activities by 48%. HDL3-UC (acyl group acceptor) and -PL (enzyme substrate) were diminished respectively by 47% and 82%, whereas HDL&lt;sub&gt;2&lt;/sub&gt;-CE concentrations (product of LCAT reaction) were increased by 44%. Moreover, HDL-C levels were found to be positively correlated with PON1 activity (r=0.96, &lt;em&gt;p&lt;/em&gt;&amp;lt;0.05). Serum, LDL-HDL&lt;sub&gt;1&lt;/sub&gt;, HDL&lt;sub&gt;2&lt;/sub&gt; and HDL&lt;sub&gt;3&lt;/sub&gt; TBARS levels were respectively, 2.9-, 2.6-, 2.4- and 2.8-fold lower in &lt;em&gt;Portulaca oleracea&lt;/em&gt; treated than untreated diabetic groups. &lt;strong&gt;Conclusion:&lt;/strong&gt; These findings reflect the potential antihyperglycemic and hypolipidemic of &lt;em&gt;Portulaca oleracea&lt;/em&gt; extract, in STZ-induced diabetic rat. Moreover,&lt;em&gt; Portulaca oleracea&lt;/em&gt; extract restores PON1 and ameliorates the reverse cholesterol transport (RCT) by enhancing LCAT activity, therefore could prevent many diabetic complications by reducing dyslipidemia and oxidative damage.&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Key words: &lt;/strong&gt;Rats, Streptozotocin, &lt;em&gt;Portulaca oleracea&lt;/em&gt;, Cholesterol, PON1, LCAT, apo A-I, lipoprotein peroxidation.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Guenzet Akila, Krouf Djamil and Berzou Saadia&lt;/strong&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;Laboratoire de Nutrition Clinique et M&amp;eacute;tabolique, D&amp;eacute;partement de Biologie, Facult&amp;eacute; des Sciences de la Nature et de la Vie. Universit&amp;eacute; d&amp;rsquo;Oran. 31100 Oran, Alg&amp;eacute;rie.&lt;/p&gt;</style></auth-address></record></records></xml>